Molecular Characterisation of Colorectal Cancer Peritoneal Metastases
ConditionColorectal Cancer Metastatic
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe Christie NHS Foundation Trust
About this trial
This project aims to characterise the tumour cell and tumour microenvironment of colorectal cancer peritoneal metastases, understand molecular changes leading to colorectal peritoneal metastasis, identify potential biomarkers and novel treatment strategies.
Eligibility criteria
Qualifiers
Patients ≥ 18 years old who have been diagnosed with colorectal cancer and have colorectal peritoneal metastases,
have had cytoreductive surgery at the Christie
have availability of archival tumour tissue (paired CRC and CRPM)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Retrospective tissue sample analysis
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
The Christie NHS Foundation Trust
Lead sponsor
University of Manchester
Collaborator
Source ClinicalTrials.gov